Surgery Partners Stock Return On Equity
| SGRY Stock | USD 24.53 0.47 1.88% |
Surgery Partners fundamentals help investors to digest information that contributes to Surgery Partners' financial success or failures. It also enables traders to predict the movement of Surgery Stock. The fundamental analysis module provides a way to measure Surgery Partners' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgery Partners stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (0.01) | (0.01) |
Surgery | Return On Equity |
Surgery Partners Company Return On Equity Analysis
Surgery Partners' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Surgery Partners Return On Equity | 0.0407 |
Most of Surgery Partners' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Surgery Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for Surgery Partners is extremely important. It helps to project a fair market value of Surgery Stock properly, considering its historical fundamentals such as Return On Equity. Since Surgery Partners' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Surgery Partners' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Surgery Partners' interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Surgery Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Surgery Partners has a Return On Equity of 0.0407. This is 100.17% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 113.13% lower than that of the firm.
Surgery Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.Surgery Partners is currently under evaluation in return on equity category among related companies.
Surgery Fundamentals
| Return On Equity | 0.0407 | ||||
| Return On Asset | 0.0383 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 7.35 B | ||||
| Shares Outstanding | 127.1 M | ||||
| Shares Owned By Insiders | 1.09 % | ||||
| Shares Owned By Institutions | 98.91 % | ||||
| Number Of Shares Shorted | 8.6 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.68 X | ||||
| Price To Sales | 1.22 X | ||||
| Revenue | 2.74 B | ||||
| Gross Profit | 574.9 M | ||||
| EBITDA | 526.6 M | ||||
| Net Income | (11.9 M) | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 3.06 B | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 15.79 X | ||||
| Cash Flow From Operations | 293.8 M | ||||
| Short Ratio | 11.02 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 42.36 | ||||
| Number Of Employees | 10.5 K | ||||
| Beta | 2.74 | ||||
| Market Capitalization | 3.12 B | ||||
| Total Asset | 7.02 B | ||||
| Retained Earnings | (569.2 M) | ||||
| Working Capital | 372 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
| Net Asset | 7.02 B |
About Surgery Partners Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Surgery Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surgery Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgery Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgery Partners Stock:Check out Surgery Partners Piotroski F Score and Surgery Partners Altman Z Score analysis. For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Surgery Stock analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share 21.839 | Quarterly Revenue Growth 0.04 | Return On Assets 0.0383 | Return On Equity 0.0407 |
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.